BIOCON
|
The Current P/B Ratio of BIOCON is 2.13.
Share Price | ₹344.8 | Dec 24,2024 |
Market Cap | ₹41,396.7 Cr | |
Book Value | ₹19,463.6 Cr | Mar2024 - Consolidated Results |
Price/Book | 2.13x | Calculated as MarketCap/Book Value |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PB (Price/Book ) ratio of BIOCON
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹41,396.7 Cr] as on Dec 24,2024
(/) Book Value [ ₹19,463.6 Cr] based on Mar2024 - Consolidated Results
(=) P/B Ratio [ 2.13x ]
Thus, for BIOCON , the investors are currently willing to pay '2.13 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of BIOCON !
The chart below summarizes the trend in P/B Ratio of BIOCON over the last five years.
Historical PB (Price/Book ) ratio chart of BIOCON
PB Ratio Performance Analysis for BIOCON
- BIOCON 's p/b ratio for fiscal years ending Mar2024 to Mar2020 averaged 3.88x.
- BIOCON 's operated at median p/b ratio of 4.88x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, BIOCON 's p/b ratio peaked in Mar2021 at 6.57x.
- BIOCON 's p/b ratio hit its five-year low in Mar2023 of 1.41x.
How does BIOCON 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
---|---|---|---|
BIOCON | 19,463.60 | 2.13 | 41,396.7 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 63,666.80 | 6.85 | 436,103.0 |
CIPLA LTD | 26,619.90 | 4.48 | 119,196.0 |
DR REDDYS LABORATORIES LTD | 28,123.50 | 4.01 | 112,752.0 |
ZYDUS LIFESCIENCES LTD | 19,829.50 | 4.89 | 97,041.2 |
DIVIS LABORATORIES LTD | 13,571.00 | 11.31 | 153,540.0 |
MANKIND PHARMA LTD | 9,339.84 | 12.86 | 120,073.0 |
TORRENT PHARMACEUTICALS LTD | 6,856.15 | 16.79 | 115,112.0 |
LUPIN LTD | 14,175.80 | 6.98 | 98,925.3 |
AUROBINDO PHARMA LTD | 29,842.80 | 2.46 | 73,314.6 |
ABBOTT INDIA LTD | 3,658.73 | 16.53 | 60,480.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs BIOCON 's P/B Ratio
Top 10 Industry Peers | PB Ratio |
---|---|
Min industry PB | 2.13x |
Max industry PB | 16.79x |
Median industry PB | 6.85x |
Average industry PB | 8.12x |
You may also like the below Video Courses